ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,804Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 457

$800K Total Retail Price of All Prescriptions

Rank: 65 out of 457

850 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 850 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 850 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 14,113 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 1,033 549 S3 1 23
SIMVASTATIN 780 677 2 2
OMEPRAZOLE 732 535 3 1
LISINOPRIL 705 567 4 3
LEVOTHYROXINE SODIUM 680 545 5 5
AMLODIPINE BESYLATE 617 545 6 4
ATORVASTATIN CALCIUM 552 437 7 33
METFORMIN HCL 528 406 8 6
MELOXICAM 483 351 9 41
LOSARTAN POTASSIUM 467 447 10 18
PRAVASTATIN SODIUM 442 345 11 29
HYDROCHLOROTHIAZIDE 412 357 12 8
WARFARIN SODIUM 336 304 13 38
METOPROLOL SUCCINATE 301 229 14 21
GABAPENTIN 290 170 15 15
FUROSEMIDE 282 249 16 10
ZOLPIDEM TARTRATE 262 177 17 13
ALENDRONATE SODIUM 262 225 17 16
METOPROLOL TARTRATE 258 219 19 7
ATENOLOL 237 214 20 11
CARVEDILOL 197 190 21 20
TRAMADOL HCL 192 143 22 26
SERTRALINE HCL 192 119 22 57
LOVASTATIN 173 141 24 25
KLOR-CON 10 153 130 25 161
LOSARTAN-HYDROCHLOROTHIAZIDE 153 132 25 54
OXYCODONE HCL 150 34 S2 27 58
AZITHROMYCIN 150 119 27 44
BUPROPION HCL SR 149 90 29 345
PANTOPRAZOLE SODIUM 149 113 29 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 147 126 31 37
ENALAPRIL MALEATE 146 135 32 35
CITALOPRAM HBR 143 103 33 45
POTASSIUM CHLORIDE 140 105 34 28
ALLOPURINOL 137 129 35 47
FENOFIBRATE 116 87 36 46
RANITIDINE HCL 113 61 37 17
CLOPIDOGREL 99 88 38 19
OXYCODONE HCL-ACETAMINOPHEN 98 16 S2 39 130
PREDNISONE 97 68 40 95
CIPROFLOXACIN HCL 97 86 40 71
DONEPEZIL HCL 95 83 42 22
JANTOVEN 94 86 43 396
FLUTICASONE PROPIONATE 91 68 44 40
GLIPIZIDE 89 78 45 42
GLIMEPIRIDE 89 61 45 75
CARISOPRODOL 89 0 R 45 150
BENAZEPRIL HCL 87 61 48 114
LEVEMIR 85 63 49 225
DIGOXIN 83 80 50 69
TAMSULOSIN HCL 82 73 51 36
TOPIRAMATE 82 26 51 403
PAROXETINE HCL 81 64 53 68
VENTOLIN HFA 80 50 54 96
RISPERIDONE 77 52 55 102
OXYBUTYNIN CHLORIDE 76 63 56 142
GLYBURIDE 73 72 R 57 64
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 52 58 153
NAMENDA 69 69 58 32
BACLOFEN 66 45 60 141
NIFEDICAL XL 66 62 60 178
CLONIDINE HCL 65 56 62 52
SYMBICORT 65 37 62 106
ROPINIROLE HCL 63 53 64 191
NITROSTAT 63 48 64 167
ESCITALOPRAM OXALATE 62 48 66 61
LEVETIRACETAM 61 32 67 160
SUMATRIPTAN SUCCINATE 60 21 68 295
PROAIR HFA 60 22 68 66
MORPHINE SULFATE ER 58 0 S2 70 136
INSULIN SYRINGE 57 49 71 79
CALCITRIOL 56 55 72 365
ISOSORBIDE MONONITRATE ER 53 32 73 84
FINASTERIDE 52 49 74 85
METHYLPREDNISOLONE 52 39 74 155
TRAZODONE HCL 51 14 76 104
CALCITONIN-SALMON 51 49 76 285
CRESTOR 50 32 78 9
FLUCONAZOLE 50 39 78 255
METFORMIN HCL ER 50 50 78 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 18, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.